Diphtheria tetanus toxoid and pertussis first-dose (DTP1) in Côte d'Ivoire
Côte d'Ivoire: Diphtheria tetanus toxoid and pertussis first-dose (DTP1) was 84.0% in 2025. ▲ Rising
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) in Côte d'Ivoire, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Côte d'Ivoire recorded 84.0% for diphtheria tetanus toxoid and pertussis first-dose (dtp1) in 2025.
The figure is up 3.7% on the previous year and down 12.5% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis first-dose (dtp1) in Côte d'Ivoire peaked at 98.0% in 2016 and was at its lowest, 71.0%, in 2003.
That places Côte d'Ivoire 160th out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) in Côte d'Ivoire, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 85.0% | — |
| 2001 | 81.0% | -4.7% |
| 2002 | 76.0% | -6.2% |
| 2003 | 71.0% | -6.6% |
| 2004 | 73.0% | +2.8% |
| 2005 | 83.0% | +13.7% |
| 2006 | 95.0% | +14.5% |
| 2007 | 93.0% | -2.1% |
| 2008 | 89.0% | -4.3% |
| 2009 | 95.0% | +6.7% |
| 2010 | 87.0% | -8.4% |
| 2011 | 74.0% | -14.9% |
| 2012 | 93.0% | +25.7% |
| 2013 | 83.0% | -10.8% |
| 2014 | 92.0% | +10.8% |
| 2015 | 96.0% | +4.3% |
| 2016 | 98.0% | +2.1% |
| 2017 | 93.0% | -5.1% |
| 2018 | 96.0% | +3.2% |
| 2019 | 94.0% | -2.1% |
| 2020 | 87.0% | -7.4% |
| 2021 | 85.0% | -2.3% |
| 2022 | 83.0% | -2.4% |
| 2023 | 82.0% | -1.2% |
| 2024 | 81.0% | -1.2% |
| 2025 | 84.0% | +3.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.1% | 71.0% | 95.0% | 10 |
| 2010s | 90.6% | 74.0% | 98.0% | 10 |
| 2020s | 83.7% | 81.0% | 87.0% | 6 |
Countries ranked near Côte d'Ivoire
More health data for Côte d'Ivoire
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 864.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 32,592 deaths (2100)
- Population ages 60-64, female, annual growth rate 3.85 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0082 units per person (2025)
- Population ages 60-64, male, annual growth rate 4 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0087 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis first-dose (dtp1) in Côte d'Ivoire?
- Diphtheria tetanus toxoid and pertussis first-dose (dtp1) in Côte d'Ivoire was 84.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis first-dose (dtp1) recorded in Côte d'Ivoire?
- The highest recorded value was 98.0% in 2016.
- What is the lowest diphtheria tetanus toxoid and pertussis first-dose (dtp1) recorded in Côte d'Ivoire?
- The lowest recorded value was 71.0% in 2003.
- How does Côte d'Ivoire rank for diphtheria tetanus toxoid and pertussis first-dose (dtp1)?
- Côte d'Ivoire ranks 160th out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis first-dose (dtp1) rising or falling in Côte d'Ivoire?
- Over the last ten years it is down 12.5%. The long-run trend across the full record is rising.
- Where does this Côte d'Ivoire data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).